Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Erythromycin
Amdipharm Limited
J01FA; J01FA01
Erythromycin
125 mg/5ml
Granules for oral suspension
Product subject to prescription which may not be renewed (A)
Macrolides; erythromycin
Not marketed
1999-02-19
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ERYTHROPED _®_ PI SF 125 MG/5 ML GRANULES FOR ORAL SUSPENSION ERYTHROPED _®_ SF 250 MG/5 ML GRANULES FOR ORAL SUSPENSION Erythromycin ethylsuccinate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. _ _ - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. Throughout the leaflet the medicine is referred to as “Erythroped Granules”, but it may have been given to you to give to your child. In that case, remember that the information will apply to your child, and not to you. The name of your medicine is Erythroped PI SF 125 mg/ 5ml Granules for Oral Suspension or Erythroped SF 250 mg/5 ml Granules for Oral Suspension or Erythroped Forte SF 500 mg/5 ml Granules for Oral Suspension (all will be referred to Erythroped Granules throughout this leaflet). WHAT IS IN THIS LEAFLET _ _ 1. What Erythroped Granules are and what they are used for 2. What you need to know before you take Erythroped Granules 3. How to take Erythroped Granules 4. Possible side effects 5. How to store Erythroped Granules 6. Contents of the pack and other information 1 WHAT ERYTHROPED GRANULES ARE AND WHAT THEY ARE USED FOR Erythroped Granules contains the active substance erythromycin as erythromycin ethylsuccinate. They belong to a group of drugs called antibiotics and are used in adults and children to treat infections caused by bacteria. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ERYTHROPED GRANULES Do not take Erythroped Granules: • if you are allergic to erythromycin or any of the other ingredients of this medicine (listed in section 6). • if you Read the complete document
Health Products Regulatory Authority 08 May 2023 CRN00DFY3 Page 1 of 9 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Erythroped PI SF 125mg/5ml granules for oral suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Contains erythromycin (as erythromycin ethylsuccinate) 125 mg/5 ml Excipients with known effect Sorbitol (1182 mg/5 ml) Sodium citrate (255 mg/ 5 ml) Saccharin sodium (3.4 mg/ 5 ml) Sodium methyl hydroxybenzoate (5 mg/5 ml) Sodium propyl hydroxybenzoate (1 mg/ 5 ml) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Granules for oral suspension White, free flowing granules with a banana flavour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Erythroped PI SF 125 mg/5 ml Granules for Oral Suspension are indicated in adults and children for the treatment of infections caused by erythromycin sensitive organisms. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _ _ Presentations are available for adults and children over 8 years, children aged 2-8 years, and for children under 2 years. _Adults and children over 8 years:_ 1 to 2 g/day in divided doses. For severe infections up to 4 g/day in divided doses. _Hepatic impairment _ Erythromycin should be used with caution in patients with impaired hepatic function (see sections 4.4 & 5.2). _Paediatric population_ _Children 2 - 8 years: _ 30 mg/kg/day in divided doses. For severe infections up to 50 mg/kg/day in divided doses. Normal dose: 250 mg four times a day or 500 mg twice daily. _Children up to 2 years:_ 30 mg/kg/day in divided doses. For severe infections up to 50 mg/kg/day in divided doses. Normal dose: 125 mg four times a day or 250 mg twice daily. Method of administration Health Products Regulatory Authority 08 May 2023 CRN00DFY3 Page 2 of 9 For oral administration Erythroped PI SF 125 mg/5 ml Granules for Oral Suspension may be administered without regard to meals. 4.3 CONTRAINDICATIONS Hypersensitivity to Read the complete document